Show simple item record

dc.creatorMichaud Ch.,Patricio
dc.date1998-07-01
dc.date.accessioned2019-05-02T21:10:32Z
dc.date.available2019-05-02T21:10:32Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98871998000700015
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/80936
dc.descriptionConsensus porposal on the use of iodine-131 in hyperthyroidism and thyroid cancer A consensus meeting held by the Chilean Endocrinological Society reached to 22 consensus proposals on the use of iodine-131 in hyperthyroidism and thyroid cancer, that are reported in this paper. Some of these propositions are: 1) Hyperthyroidism: A previous 131I uptake test must be performed. A calculated or an ablative dose should be administered. Hypothyroidism must be considered an objective rather than a complication. In patients with cardiovascular risk, normal thyroid function must be attained with propythioturacil. In cases of treatment failure, the dose should not be repeated before six months. It must be used with used with caution in children and teenagers. 2) Thyroid cancer: A iodine free diet is recommended prior to the therapeutic dose. A 100 mCi complementary ablative dose should be given after surgery, with a posterior exploration. This examination must not be done routinely, and if required, a 5 mCi dose should be used. For the treatment of metastases, a dose of 150 to 200 mCi is recommended. There is no radiation risk in hyperthyroidism or thyroid cancer. The only absolute contraindication is pregnancy. Recommendations for radiological protection are formulated. Hospitalization is suggested to protect other people from radiation exposure.
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.relation10.4067/S0034-98871998000700015
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista médica de Chile v.126 n.7 1998
dc.subjectThyroid diseases
dc.subjectgoiter
dc.subjectGravesÕ disease
dc.subjectThyrotoxicosis
dc.subjectThyroid neoplasms
dc.subjectIodine radioisotopes, therapeutic
dc.titleProposición de consenso para el uso de yodo 131 en el tratamiento de la tirotoxicosis y el cáncer del tiroides


This item appears in the following Collection(s)

Show simple item record